Introduction
IAS Panel Members
Innovations 1
Innovations 2
International Position Paper
Purposes of Position Paper
LDL-C and Non-HDL-C
Advantages of Non-HDL-C
Atherogenic Cholesterol
Optimal Levels of LDL-C and Non-HDL-C
Identifying Persons at Long-term Risk for ASCVD
Factors Affecting Long-term Risk for ASCVD
Levels of Long-term Risk for ASCVD
Lloyd-Jones/Framingham Risk for Algorithm
Risk for CVD Morbidity by Age 80
Framingham Heart Study
Framingham Heart Study
Qualitative High-Risk Condition
Long-term Risk Algorithms
IAS Recommendations for Cholesterol-Lowering Therapy
1 of 20